ABUS vs BB
Arbutus Biopharma Corp (ABUS) versus BlackBerry Ltd (BB) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. BB currently screens at market cap $6.14B and trailing P/E 116.5.
Not investment advice. Open the ABUS and BB stock pages for the full models.
Not investment advice.